+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acerus Pharmaceuticals Corp (ASP) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 53 Pages
  • December 2021
  • GlobalData
  • Acerus Pharma
  • ID: 4085315
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Allergan Ltd
  • Amgen Canada Inc
  • Merck Canada Inc
  • Paladin Labs Inc
  • Titan Medical Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Acerus Pharmaceuticals Corp (ASP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets and distributes novel innovative branded products. It focuses in the therapeutic areas of women’s health (female sexual dysfunction, harmone replacement therapy) and men’s health (urology). The company’s marketed products include Estrace, for menopausal symptoms and Natesto, a testosterone for male hypogonadism. Acerus pipeline products include Tefina, Avanafil, Elegant and Lidbree indicated for various health issues related to men and women. The company sells products through its salesforce in Canada and licensed distributors in the US and other countries. The company is headquartered in Mississauga, Ontario, Canada.

Acerus Pharmaceuticals Corp Key Recent Developments


  • Nov 09,2021: Acerus Reports Fiscal Third Quarter Financial Results
  • Aug 12,2021: Acerus reports acceptance of part 36 settlement offer in recipharm litigation
  • Aug 10,2021: Acerus Reports Fiscal 2021 Second Quarter Financial Results
  • Jul 12,2021: Acerus provides update on litigation with Recipharm
  • Jun 14,2021: Acerus Announces Voting Results for the 2021 Annual Meeting

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

FEATURED COMPANIES

  • Allergan Ltd
  • Amgen Canada Inc
  • Merck Canada Inc
  • Paladin Labs Inc
  • Titan Medical Inc

Section 1 - About the Company
  • Acerus Pharmaceuticals Corp - Key Facts
  • Acerus Pharmaceuticals Corp - Key Employees
  • Acerus Pharmaceuticals Corp - Key Employee Biographies
  • Acerus Pharmaceuticals Corp - Major Products and Services
  • Acerus Pharmaceuticals Corp - History
  • Acerus Pharmaceuticals Corp - Company Statement
  • Acerus Pharmaceuticals Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • Acerus Pharmaceuticals Corp - Business Description
  • R&D Overview
  • Acerus Pharmaceuticals Corp - Corporate Strategy
  • Acerus Pharmaceuticals Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Acerus Pharmaceuticals Corp - Strengths
  • Acerus Pharmaceuticals Corp - Weaknesses
  • Acerus Pharmaceuticals Corp - Opportunities
  • Acerus Pharmaceuticals Corp - Threats
  • Acerus Pharmaceuticals Corp - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Acerus Pharmaceuticals Corp, Recent Deals Summary

Section 5 - Company’s Recent Developments
  • Nov 09, 2021: Acerus Reports Fiscal Third Quarter Financial Results
  • Aug 12, 2021: Acerus reports acceptance of part 36 settlement offer in recipharm litigation
  • Aug 10, 2021: Acerus Reports Fiscal 2021 Second Quarter Financial Results
  • Jul 12, 2021: Acerus provides update on litigation with Recipharm
  • Jun 14, 2021: Acerus Announces Voting Results for the 2021 Annual Meeting
  • Mar 11, 2021: Acerus Reports Fourth Quarter and Full Year 2020 Financial Results
  • Mar 04, 2021: Acerus to Report 2020 Financial Results and Host Investor Call
  • Nov 03, 2020: Acerus reports fiscal third quarter financial results
  • Sep 14, 2020: Acerus announces addition of US commercial leader
  • Aug 11, 2020: Acerus reports fiscal 2020 second quarter financial results

Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About The Publisher
  • Contact The Publisher
  • Disclaimer

List of Tables
  • Acerus Pharmaceuticals Corp, Key Facts
  • Acerus Pharmaceuticals Corp, Key Employees
  • Acerus Pharmaceuticals Corp, Key Employee Biographies
  • Acerus Pharmaceuticals Corp, Major Products and Services
  • Acerus Pharmaceuticals Corp, History
  • Acerus Pharmaceuticals Corp, Subsidiaries
  • Acerus Pharmaceuticals Corp, Key Competitors
  • Acerus Pharmaceuticals Corp, Ratios based on current share price
  • Acerus Pharmaceuticals Corp, Annual Ratios
  • Acerus Pharmaceuticals Corp, Interim Ratios
  • Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Acerus Pharmaceuticals Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Acerus Pharmaceuticals Corp, Performance Chart (2016 - 2020)
  • Acerus Pharmaceuticals Corp, Ratio Charts
  • Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

Loading
LOADING...

A selection of companies mentioned in this report includes:

  • Upsher-Smith Laboratories LLC
  • Titan Medical Inc
  • Paladin Labs Inc
  • Merck Canada Inc
  • Invaron Pharmaceuticals Inc
  • Amgen Canada Inc
  • Allergan Ltd